Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
The New York Post highlighted 2 studies published in The American Journal of Managed Care® (AJMC®) in its article that reported on Governor Andrew Cuomo signing an executive order to allow pharmacists to give flu shots. The first study, “Retail Clinic Utilization Associated With Lower Total Cost of Care,” found that there were savings associated with retail clinic usage and these savings were derived from decreased physician office and hospital visit expenses. The second study, “Quality of Care at Retail Clinics for 3 Common Conditions,” found that the quality of care for 3 different conditions was superior in MinuteClinics compared with ambulatory care facilities or emergency departments.
Monday’s OBR daily included an article from AJMC®. The article, “Oncologists Overcome Hurdles to Deliver Cancer Care in Puerto Rico,” reported on interviews with doctors and organizations who told AJMC® that even though much more remains to be done on an island where half of its residents still lack power, the situation is improving for patients with cancer.
An article in Healthcare Informatics cited a study published in AJMC® that found 40% of ambulatory care practices are “under-users” of electronic health record (EHR) tools. The study, “Electronic Health Record ‘Super-Users’ and ‘Under-Users’ in Ambulatory Care Practices,” concluded that to achieve the broader benefits of the EHR and health information technology (IT), health systems and policy makers need to identify and address barriers to full use of health IT functionalities.
Thursday’s National Pharmaceutical Council’s CER Daily Newsfeed included an article from AJMC® on personalized medicine. The article, “FDA Approved a Record Number of Personalized Medicines in 2017,” reported that 1 in every 4 drugs approved over the past 4 years was a personalized medicine, and the agency approved a record-breaking 16 personalized therapies in the past year.
EHR Intelligence mentioned an AJMC®​​​​​​​ published study in its article on using EHRs for predictive analytics. The study, “Electronic Sharing of Diagnostic Information and Patient Outcomes,” which evaluated the association between hospital sharing of EHR diagnostic information and hospital quality, found that hospital sharing of EHR data with providers within their system is associated with reduced patient mortality; however, sharing data with providers outside their system is associated with worsened patient mortality. In another article, EHR Intelligence cited the AJMC®​​​​​​​ published study, “Electronic Health Record Problem Lists: Accurate Enough for Risk Adjustment?” The study found that EHR-based comorbidity assessment had low sensitivity for identifying major comorbidities and poorly predicted survival.
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
IQVIA Report Spotlights Shortages for Pain, Obesity, and Oncology Therapies
November 21st 2023A new report from IQVIA provides an overview of current US drug shortages, shedding light on major areas of concern, such as medications to address pain, cardiovascular conditions, obesity and diabetes, and multiple forms of cancer.
Read More
Researchers Identify Potential Biomarkers for SMA Motor Improvement Following Nusinersen Treatment
November 17th 2023A retrospective, exploratory analysis identifies biomarkers predictive of spinal muscular atrophy (SMA) response to nusinersen and suggests the efficacy of using machine learning algorithms to anticipate patient outcomes.
Read More
Data on Delandistrogene Moxeparvovec Can Inform Future Gene Therapies
November 17th 2023The FDA approved delandistrogene moxeparvovec-rokl (Elevidys, Sarepta Therapeutics) in June to treat Duchenne muscular dystrophy in ambulatory pediatric patients aged 4 through 5 who have a confirmed DMD gene mutation.
Read More